Company Highnoon Laboratories Limited

Equities

HINOON

PK0070701013

Pharmaceuticals

End-of-day quote Pakistan S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
516.5 PKR +0.39% Intraday chart for Highnoon Laboratories Limited +1.26% +2.37%

Business Summary

Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling and marketing of pharmaceutical and allied consumer products. The Company's product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Somno, Hitica, Apiban, Pidogrel-AP, Blokium DIU, Epliron, Sacuvia, Ivaset, Rivaro, Valforge and Herbesser. Its metabolic products include Xormet XR, MetFormin HCI, Diajard-MXR, Diajard-M and Diajard. The Company's gastroenterology products include Liv 52, Rabecid and Racedo. Its musculoskeletal products include Flexa Plus, Airtal ER and Tamadol. The Company's pediatric products include Bonisan, Cogniza, Flu Ace, Prospan and Tres Orix Forte. Its allergy products include Leviva and Kestine. Its Respiratory products include Combivair Forte, Sprahaler Respules, Foracort HFA Inhaler and Rotaflo.

Number of employees: 2,382

Sales per Business

PKR in Million2021Weight2022Weight Delta
Pharmaceutical
107.8 %
13,211 101.6 % 17,052 107.8 % +29.08%
Discount
-9.6 %
-425 -3.3 % -1,518 -9.6 % +257.34%
Toll Manufacturing
3.1 %
384 3.0 % 491 3.1 % +27.85%
Sales Tax
-0.7 %
-57 -0.4 % -109 -0.7 % +92.21%
Sales Return
-0.6 %
-112 -0.9 % -100 -0.6 % -11.31%

Sales per region

PKR in Million2021Weight2022Weight Delta
Pakistan
94.4 %
12,435 95.6 % 14,927 94.4 % +20.04%
Afghanistan
3.7 %
296 2.3 % 589 3.7 % +98.80%
United Arab Emirates
0.7 %
106 0.8 % 103 0.7 % -2.87%
Iraq
0.4 %
14 0.1 % 61 0.4 % +325.41%
France
0.3 %
68 0.5 % 50 0.3 % -27.03%
Tanzania
0.1 %
4 0.0 % 21 0.1 % +438.78%
Dubai
0.1 %
-- 20 0.1 % -
Cambodia
0.1 %
7 0.1 % 18 0.1 % +165.50%
Kenya
0.1 %
65 0.5 % 15 0.1 % -76.22%
Others
0.1 %
6 0.0 % 11 0.1 % +100.39%

Managers

Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 20-03-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Corporate Officer/Principal - -
Human Resources Officer - -
Corporate Secretary - -
Sales & Marketing - -
Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 23-02-23
Chairman - 83-12-31
Director/Board Member - 88-02-29
Director/Board Member - 00-09-02
Chief Executive Officer - -
Director/Board Member 34 -
Director/Board Member - 18-02-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,983,363 25,670,461 ( 48.45 %) 0 48.45 %

Shareholders

NameEquities%Valuation
National Investment Trust Ltd.
1.443 %
764,682 1.443 % 1 M ₨
UBL Fund Managers Ltd.
1.039 %
550,613 1.039 % 1 M ₨
MCB-Arif Habib Savings & Investments Ltd. (Invt Mgmt)
0.9392 %
497,641 0.9392 % 909 807 ₨
JS Investments Ltd. (Investment Management)
0.7417 %
392,997 0.7417 % 718 493 ₨
Atlas Asset Management Ltd.
0.7224 %
382,750 0.7224 % 699 759 ₨
Al Meezan Investment Management Ltd.
0.4647 %
246,196 0.4647 % 450 105 ₨
Faysal Bank Ltd. (Investment Management)
0.4126 %
218,630 0.4126 % 399 708 ₨
Alfalah Asset Management Ltd.
0.1479 %
78,352 0.1479 % 143 246 ₨
NBP Fund Management Ltd.
0.0753 %
39,873 0.0753 % 72 897 ₨
HBL Asset Management Ltd.
0.0404 %
21,388 0.0404 % 39 102 ₨

Company contact information

Highnoon Laboratories Ltd.

Tricon Corporate Centre 9th Floor Jail Road

53700, Lahore

+

http://www.highnoon-labs.com
address Highnoon Laboratories Limited(HINOON)